中文 ENGLISH
Search
Categories
Link:Lian Chuang Biomedicine
About Us

Anhui YongAn Pharmaceutical Co., Ltd, a fully owned subsidiary of Anhui Lianchuang Biological Medicine Co.,Ltd. , is dedicated to the production of pharmaceutical APIs.

YongAn Pharmaceutical is located in the Biomedical Industrial Park of Huainan National Economic and Technical Development Zone. It occupies an area of 60,000㎡ with total investment RMB200 million. Now it has established two workshops that meets GMP requirements. A workshop for the production of inhibitor SGLT-2 is under construction. In addition, the construction for GLP-1 receptor stimulant workshop is under planning as well. Auxiliary facilities include warehouses, fire equipments, environment-protection pool, R&D office building, etc.

Main products including:
Diabetes APIs: Sglt-2 inhibitors such as Dapagliflozin, Canagliflozin, Empagliflozin, etc; DPP4-1 inhibitors such as Alogliptin benzoate, etc; GLP-1 inhibitors such as Liraglutide, etc; insulin secretagogues such as Repaglinide, etc.
Non-diabetic APIs: cardiovascular series such as Rivaroxaban, Eltrombopag,etc; urinary series such as Mirabegron, etc;immunity series such as Tofacitinib, Apremilast, etc; CNS series such as Suvorexant, Rasagiline, etc; anti-tumor series such as Ibrutinib, Afatinib, etc;

Remarks: Products can be used only for research purpose and not for commercial use if they are under patent protection.

Technical support relies on below two R&D centers:

R&D center I: Anhui Lianchuang Biological Medicine Co.,Ltd. , has focused on the field of medicine for almost 10 years, possesses an excellent process development and project management team. The R&D center locates in Building 9, Li Heng Industry Square ,Economic and Technological Development Zone, Hefei , Anhui Province, China and occupies an area of 3,000㎡ with total investment RMB50 million. At present, the R&D group has 70 staffs, three of them are doctors and more than 40% of them are with master degree. It has received clinical approval for 10 new drugs. Besides, more than 100 pharmaceutical materials and intermediates have been produced commercially.
Lianchuang boasts of advanced equipments and abundant project management experience.

R&D center II: Hefei Cornfield Biotechnology Co., Ltd., a subsidiary of Anhui Lianchuang Biological Medicine Co.,Ltd., situated in the National University Science Park of Hefei New & Hi-Tech Development Zone. Chief scientist is a professor from School of Life Sciences, University of Science and Technology of China. And it devotes itself to bio-enzyme’s development and application, process development of APIs through fusion of organic synthesis and enzymatic technology, and synthesis research of polypeptide drugs.

Our manufacturing activities are in strict accordance with cGMP management practices. We attach great importance to environment protection and governance and health & safety at work. We will always pursue the mission to actively perform social responsibility and we will spare no effort to provide MAH customers and drug manufacturers around the world with quality products, technical support and services like registration and audit.
Yongan pharmaceutical will work with all the excellent partners to promote drug development and improve human health in future.

Enterprise culture:
Our mission: to improve health and to contribute to better change of human life.
Our vision: to become an international prestigious and reliable life sciences company.
Our spirit: innovation, efficiency, sincerity, and harmony.
Our goal: to provide the world with green, top-quality, and fair price pharmaceutical products.

Copyright 2018 AnHui Yongan Pharmaceutical Co., Ltd. All rights reserved. Supported by www.hxchem.net